SILINGARDI, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 7.287
EU - Europa 4.163
AS - Asia 3.672
SA - Sud America 501
AF - Africa 100
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 8
Totale 15.758
Nazione #
US - Stati Uniti d'America 7.155
IT - Italia 1.147
GB - Regno Unito 1.131
CN - Cina 1.070
SG - Singapore 1.061
SE - Svezia 452
HK - Hong Kong 408
BR - Brasile 365
VN - Vietnam 363
DE - Germania 273
FI - Finlandia 245
UA - Ucraina 231
TR - Turchia 219
FR - Francia 192
RU - Federazione Russa 183
IN - India 114
KR - Corea 85
BG - Bulgaria 73
ID - Indonesia 53
CA - Canada 49
AR - Argentina 43
NL - Olanda 42
BD - Bangladesh 40
MX - Messico 36
IQ - Iraq 31
MY - Malesia 30
ES - Italia 28
PK - Pakistan 28
ZA - Sudafrica 28
CO - Colombia 26
PL - Polonia 26
AU - Australia 24
JP - Giappone 23
SA - Arabia Saudita 21
BZ - Belize 19
EC - Ecuador 19
IE - Irlanda 18
RO - Romania 18
CL - Cile 17
CZ - Repubblica Ceca 17
BE - Belgio 16
AE - Emirati Arabi Uniti 15
IR - Iran 15
AT - Austria 13
KE - Kenya 13
NP - Nepal 13
PH - Filippine 13
MA - Marocco 12
VE - Venezuela 12
ET - Etiopia 11
CR - Costa Rica 10
LT - Lituania 10
EG - Egitto 9
TH - Thailandia 9
CH - Svizzera 8
DZ - Algeria 7
EU - Europa 7
TN - Tunisia 7
UZ - Uzbekistan 7
HU - Ungheria 6
JO - Giordania 6
KZ - Kazakistan 6
PE - Perù 6
TW - Taiwan 6
AZ - Azerbaigian 5
DK - Danimarca 5
GE - Georgia 5
IL - Israele 5
PY - Paraguay 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
EE - Estonia 4
MD - Moldavia 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
BH - Bahrain 3
CM - Camerun 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
MK - Macedonia 3
PR - Porto Rico 3
AN - Antille olandesi 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
GF - Guiana Francese 1
GH - Ghana 1
Totale 15.739
Città #
Santa Clara 823
Southend 778
Singapore 663
Ashburn 596
Fairfield 493
Chandler 455
Jacksonville 433
Hong Kong 390
Hefei 380
Woodbridge 320
Dearborn 318
San Jose 278
Houston 242
Wilmington 225
Nyköping 212
Ann Arbor 203
Council Bluffs 198
Beijing 197
Cambridge 192
Helsinki 164
Seattle 160
London 158
Los Angeles 141
Izmir 113
Ho Chi Minh City 106
The Dalles 106
Buffalo 87
Princeton 86
Hanoi 82
Seoul 79
Chicago 78
San Diego 73
Eugene 71
Sofia 71
Milan 66
New York 66
Des Moines 63
Rome 63
Lauterbourg 57
Columbus 53
Moscow 51
Jakarta 45
Dong Ket 44
Falls Church 39
Shanghai 34
São Paulo 32
Bremen 31
Orem 29
Munich 26
Salt Lake City 26
Da Nang 22
Redwood City 21
Naples 20
Belize City 19
Chennai 19
Turin 19
Modena 18
Tokyo 18
Frankfurt am Main 17
Norwalk 17
Palermo 17
Bari 16
Brussels 16
Dallas 16
Guangzhou 16
Phoenix 15
Baghdad 14
Warsaw 14
Brno 13
Buraidah 13
Dublin 13
Falkenstein 13
Johannesburg 13
Saint Petersburg 13
San Mateo 13
Tampa 13
Turku 13
Verona 13
Mexico City 12
Nanjing 12
Saint Louis 12
Toronto 12
Boardman 11
Bologna 11
Florence 11
Kunming 11
Ottawa 11
Brooklyn 10
Elk Grove Village 10
Haiphong 10
Madrid 10
Montreal 10
Philadelphia 10
Denver 9
Kent 9
Livorno 9
Nairobi 9
Rio de Janeiro 9
Torino 9
Auburn Hills 8
Totale 10.365
Nome #
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta 760
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 525
Il morbo di Hodgkin sclero-nodulare. Studio clinico-patologico 484
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. 367
Patogenesi complessa di una emopatia sistemica: la tricoleucemia 330
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 306
PROMECE-CYTABOM VS MACOP-B IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - LONG-TERM RESULTS OF A MULTICENTER STUDY OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL) 303
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. 296
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 294
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS 292
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: The Gruppo Italiano per lo Studio dei Linfomi Experience 290
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes. 289
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer 284
A pilot study on the use of the ProMACE CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma 276
EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL 274
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal 274
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 269
A report of seven long survivors for evidence of prognostic factors in hairy cell leukemia 268
STIFF-MAN SYNDROME IN A PATIENT WITH HODGKINS-DISEASE - AN UNUSUAL PARANEOPLASTIC SYNDROME 265
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 258
Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting 254
Comment on "Cancer genetic counselling' by P.!Mandich et al. (Ann Oncol 2005; 16: 171) 244
A multicenter randomized trial of two different ProMACE-CytaBOM derived protocols in aggressive non-Hodgkin's Lymphomas (NHL). A preliminary report 242
Alimentazione e tumori II. Le vitamine 240
Bone marrow infiltration in Hairy cell leukemia after interferon therapy detected by magnetic resonance imagin 240
Hereditary risk of breast cancer: not only brca 239
Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin 237
Leucemia e tricoleucociti: studio clinico patologico di 30 casi 235
Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study 233
Detection of bone marrow involvement in patients with cancer 232
ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+/KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS 231
Trapianto di midollo osseo nelle aplasie midollari. 230
Hodgkin's disease prognosis: a directly predictive equation 230
HAIRY-CELL LEUKEMIA - A CLINICAL REVIEW BASED ON 725 CASES OF THE ITALIAN-COOPERATIVE-GROUP (ICGHCL) 228
Profilassi del vomito nei pazienti affetti da linfoma non-Hodgkin trattati con il protocollo ProMECE-CytaBOM. Risultati preliminari di uno studio clinico controllato 220
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monodenopathic variety 217
Studio clinico immunologico di sei casi di morbo di Behcet 212
Prevention of cisplatin induced vomiting in patients with cancer. A pilot study with a multiagent protocol 209
Screening clinico, mammografico e genetico del carcinoma mammario ereditario 206
Usefulness of breast MRI in a patient with genetic risk 206
Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form 201
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease 200
Alimentazione e tumori I. Considerazioni dietetiche generali: gli alimenti 200
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group 199
Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL) 198
Alimentazione e tumori III. Gli oligoelementi 197
Istiocitosi maligna 193
Validation of the international prognostic index in working formulation group a low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo studio dei linfomi registry. 191
Utilità della Risonanza Magnetica Nucleare nello studio del midollo osseo di pazienti affetti da hairy Cell Leukemia 190
Hairy cell leukemia: a reversible disease? A report of two cases of spontaneous remission 189
Long term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian cooperative group for HCL 187
Relationship between prognostic factors and therapy in high grade non Hodgkin's lymphomas over two decades 187
The excretion of tryptophan metabolites in patients with different forms of haemoblastosis 186
Human lymphoblastoid interferon as initial therapy in hairy cell leukemia: a multicenter study in non-splenectomized patients 185
Utilità diagnostica della risonanza magnetica nucleare in onco-ematologia 175
Gli interferoni in terapia antineoplastica 173
Cancer Incidence in the Province of Modena. Cancer Incidence in Five Continents Vol.VII 167
Free from failure survival in Hodgkin's disease. Long term analysis of 148 cases treated with a MOPP modified protocol 166
Ruolo attuale della chemioterapia nel carcinoma transizionale della vescica muscolo-invasivo 165
La chemioprevenzione del carcinoma mammario 164
PROMACE-CYTABOM VERSUS MACOP-B IN INTERMEDIATE AND HIGH-GRADE NHL - PRELIMINARY-RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL 156
La strategia terapeutica del GISL nei linfomi non-Hodgkin 154
REGIMEN-RELATED LIVER TOXICITY IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION 149
METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN AND CISPLATIN (M-VEC) IN PATIENTS WITH LOCALLY ADVANCED TRANSITIONAL BLADDER-CANCER 145
La predisposizione genetica al cancro dell'ovaio. Individuazione e sorveglianza delle donne a rischio 139
Immunohistochemical labeling index in breast cancer after in vivo administration of bromodeoxiuridine 131
Emopoiesi extramidollare endotoracica in Morbo di Cooley dell'adulto 122
Totale 15.998
Categoria #
all - tutte 51.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.847


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021332 0 0 0 0 0 0 0 0 0 127 80 125
2021/20221.294 28 159 111 129 40 105 72 64 149 73 223 141
2022/20231.403 123 130 109 125 180 238 18 131 173 24 58 94
2023/2024826 44 45 50 84 147 68 143 66 9 34 35 101
2024/20252.874 117 39 50 222 609 422 221 201 319 84 279 311
2025/20264.241 298 264 506 362 569 477 569 218 544 434 0 0
Totale 15.998